Chuanyuan Chen

3.7k total citations · 3 hit papers
7 papers, 1.6k citations indexed

About

Chuanyuan Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Chuanyuan Chen has authored 7 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 1 paper in Cardiology and Cardiovascular Medicine and 1 paper in Oncology. Recurrent topics in Chuanyuan Chen's work include RNA modifications and cancer (4 papers), Cancer-related gene regulation (4 papers) and CRISPR and Genetic Engineering (2 papers). Chuanyuan Chen is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related gene regulation (4 papers) and CRISPR and Genetic Engineering (2 papers). Chuanyuan Chen collaborates with scholars based in China, United States and Germany. Chuanyuan Chen's co-authors include Dali Han, Meng Xu, Chuan He, Bin Shen, Jun Liu, Marc B. Bissonnette, Urszula Dougherty, Renbao Chang, Yi Liu and Xiaona Huang and has published in prestigious journals such as Nature, Science and Cancer Cell.

In The Last Decade

Chuanyuan Chen

7 papers receiving 1.6k citations

Hit Papers

Anti-tumour immunity controlled through mRNA m6A methylat... 2019 2026 2021 2023 2019 2020 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuanyuan Chen China 7 1.5k 739 216 168 143 7 1.6k
Jinqiu He China 7 1.2k 0.8× 519 0.7× 107 0.5× 95 0.6× 227 1.6× 12 1.4k
Benoit Molinié United States 10 2.7k 1.8× 1.4k 1.9× 132 0.6× 151 0.9× 251 1.8× 14 2.9k
Sheng Lu China 12 442 0.3× 242 0.3× 75 0.3× 93 0.6× 67 0.5× 26 665
Zhan‐Cheng Zeng China 16 711 0.5× 455 0.6× 95 0.4× 66 0.4× 37 0.3× 20 836
Sung‐Yul Lee South Korea 10 916 0.6× 679 0.9× 81 0.4× 101 0.6× 3 0.0× 29 1.1k
Helen Loo Yau Canada 6 924 0.6× 182 0.2× 335 1.6× 514 3.1× 5 0.0× 12 1.3k
Alexander M. Price United States 16 352 0.2× 129 0.2× 393 1.8× 187 1.1× 30 0.2× 21 772
Marja van Meijer Netherlands 13 453 0.3× 224 0.3× 223 1.0× 159 0.9× 6 0.0× 18 919
Sumanprava Giri United States 10 927 0.6× 572 0.8× 83 0.4× 36 0.2× 3 0.0× 11 1.0k
Cathrin Ritter Germany 14 199 0.1× 69 0.1× 647 3.0× 258 1.5× 256 1.8× 23 840

Countries citing papers authored by Chuanyuan Chen

Since Specialization
Citations

This map shows the geographic impact of Chuanyuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanyuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanyuan Chen more than expected).

Fields of papers citing papers by Chuanyuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuanyuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanyuan Chen. The network helps show where Chuanyuan Chen may publish in the future.

Co-authorship network of co-authors of Chuanyuan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chuanyuan Chen. A scholar is included among the top collaborators of Chuanyuan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuanyuan Chen. Chuanyuan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Liang, Guanghao, Qiancheng You, Kirk E. Cahill, et al.. (2023). Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy. Advanced Science. 10(23). e2300445–e2300445. 8 indexed citations
2.
Chen, Chuanyuan, Yawei Zhang, Zhenghang Wang, et al.. (2021). The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth. Cancer Cell. 39(7). 945–957.e10. 201 indexed citations breakdown →
3.
Liu, Jun, Xiaoyang Dou, Chuanyuan Chen, et al.. (2020). N 6 -methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science. 367(6477). 580–586. 495 indexed citations breakdown →
4.
Teng, Fei, Jing Li, Tongtong Cui, et al.. (2019). Enhanced mammalian genome editing by new Cas12a orthologs with optimized crRNA scaffolds. Genome biology. 20(1). 15–15. 82 indexed citations
5.
Han, Dali, Jun Liu, Chuanyuan Chen, et al.. (2019). Author Correction: Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 568(7751). E3–E3. 22 indexed citations
6.
Han, Dali, Jun Liu, Chuanyuan Chen, et al.. (2019). Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 566(7743). 270–274. 737 indexed citations breakdown →
7.
Gu, Tongnian, Siqi Zhao, Weizhong Chen, et al.. (2018). Highly efficient base editing in Staphylococcus aureus using an engineered CRISPR RNA-guided cytidine deaminase. Chemical Science. 9(12). 3248–3253. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026